Effectiveness and safety of anti-CD19 chimeric antigen receptor-T cell immunotherapy in patients with Relapsed/Refractory Large b-cell lymphoma: a systematic …
Z Ying, Y Song, J Zhu - Frontiers in Pharmacology, 2022 - frontiersin.org
Aim: To investigate the effectiveness and safety of using chimeric antigen receptor (CAR) T
cell therapies targeting CD19 in patients with diffuse large B-cell lymphoma (DLBCL) …
cell therapies targeting CD19 in patients with diffuse large B-cell lymphoma (DLBCL) …